Purity > 99.0 %
AEE-788 is an orally bioavailable multiple-receptor tyrosine kinase inhibitor. AEE-788 inhibits phosphorylation of EGFR, HER2, and VEGF2, resulting in receptor inhibition, the inhibition of cellular proliferation, and induction of tumor cell and tumor-associated endothelial cell apoptosis. AEE-788 is in clinical trials.
Free Shipping within the Continental USA